STAT5B and chronic myelogenous leukemia, BCR-ABL1 positive: We demonstrated that 17f treatment reduces STAT5B protein levels in resistant CML and AML cells, suggesting that 17f overcomes chemotherapy resistance though the downregulation of this protein.